Search details
1.
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(10): 3217-3228, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37428196
2.
Long-Term Complete Response and Survival in Metastatic Extramammary Paget's Disease Treated With Trastuzumab Plus Paclitaxel: A Case Report.
Cureus
; 16(4): e58924, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38800219
3.
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.
Clin Exp Med
; 24(1): 13, 2024 Jan 20.
Article
in English
| MEDLINE | ID: mdl-38244147
4.
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis.
Target Oncol
; 19(3): 371-382, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38613732
5.
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study.
Cancers (Basel)
; 15(14)2023 Jul 14.
Article
in English
| MEDLINE | ID: mdl-37509286
6.
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
Curr Oncol
; 30(5): 5103-5115, 2023 05 17.
Article
in English
| MEDLINE | ID: mdl-37232844
7.
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Curr Oncol
; 30(6): 5456-5469, 2023 06 04.
Article
in English
| MEDLINE | ID: mdl-37366896
8.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Cancers (Basel)
; 15(24)2023 Dec 08.
Article
in English
| MEDLINE | ID: mdl-38136304
9.
Immune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival.
Cancer Diagn Progn
; 2(1): 55-63, 2022.
Article
in English
| MEDLINE | ID: mdl-35400002
10.
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Sci Rep
; 12(1): 21908, 2022 12 19.
Article
in English
| MEDLINE | ID: mdl-36535985
11.
Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis.
Cureus
; 14(10): e30607, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36299600
12.
Colon metastasis from recurrent gallbladder cancer: a case report.
AME Case Rep
; 5: 21, 2021.
Article
in English
| MEDLINE | ID: mdl-34312600
13.
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Anticancer Res
; 41(5): 2553-2561, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33952483
14.
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
Anticancer Res
; 39(9): 4917-4924, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31519596
Results
1 -
14
de 14
1
Next >
>>